Acorai Heart Monitor Granted FDA Breakthrough Designation
Acorai, a startup medical device manufacturer, announced that the FDA has granted Breakthrough Device Designation for Acorai’s Heart Monitor.
Read MoreAug 10, 2023 | Clearances | 0 |
Acorai, a startup medical device manufacturer, announced that the FDA has granted Breakthrough Device Designation for Acorai’s Heart Monitor.
Read MoreApr 27, 2023 | Medical Equipment | 0 |
Innoblative’s SIRA RFA Electrosurgical Device is intended for use in breast cancer patients undergoing BCS.
Read MoreMar 4, 2022 | FDA Updates, Patient Care Equipment | 0 |
A pilot study for a new PTSD therapeutic device supports its recent Breakthrough Device designation from the FDA.
Read MoreMar 2, 2022 | FDA Updates, Remote Monitoring | 0 |
Dexcom has been granted FDA Breakthrough Device Designation of its new continuous glucose monitoring system for use in the hospital setting.
Read MoreFeb 24, 2022 | FDA Updates, Patient Care Equipment | 0 |
Noninvasix’s LIVOx Central Venous Oxygenation Monitor has received Breakthrough Device Designation from the FDA for non-invasive Sepsis monitoring tech.
Read More